Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
B2S Life Sciences logo — We make, characterize and manage critical reagents, develop...

B2S Life Sciences

We make, characterize and manage critical reagents, develop bioanalytical methods, and offer GLP analysis and cut points

Founded 2014 United States Franklin, United States 45 employees Biotechnology

General Information

Company Name B2S Life Sciences
Founded Year 2014
Location United States Franklin, United States +1
Employees 45
Industries Biotechnology
Social

Get notified when B2S Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About B2S Life Sciences

B2S Life Sciences is a biotherapeutic enablement company specializing in bioanalytical consulting, immunoassay development, and custom biological reagent generation. Founded in 2014 and headquartered in Franklin, Indiana, the company's focus on creating, characterizing, and managing critical reagents, as well as offering GLP analysis, demonstrates its dedication to advancing human health outcomes for various disease states and chronic conditions. By providing services such as life-cycle management, immunogenicity cut point analysis, and PK/TK statistics, B2S aims to facilitate the development of much-needed cures and treatments. As of now, the company has not disclosed its latest investment or the involved investors. B2S Life Sciences operates in the Biotechnology sector and continuously strives to drive successful advancements in the field.

Taxonomy: bioanalytical consulting, immunoassay development, reagent generation, life-cycle management, immunogenicity cut point analysis, PK/TK statistics, advanced analytics, custom immunoassays, regulatory compliance, pharmacokinetic data analysis, toxicokinetic data analysis, clinical trial support

No funding data available for B2S Life Sciences yet.

Get notified when B2S Life Sciences raises funding

B2S Life Sciences Alternatives & Competitors

B2S Life Sciences vs
23andMe
23andMe United States

A nonprofit advancing health through the power of genetics and crowdsourced research.

Unknown
555 employees
Biotechnology, Life Sciences
B2S Life Sciences vs
Evadata
Evadata United States

A new venture focused on data, technology, and processing for the life and annuity industry.

11 employees
Information Technology, Life insurance
B2S Life Sciences vs
Anlitiks Inc.
Anlitiks Inc. United States

Transforming Evidence to Decisions

16 employees

FAQ About B2S Life Sciences

We make, characterize and manage critical reagents, develop bioanalytical methods, and offer GLP analysis and cut points
B2S Life Sciences was founded in 2014.
B2S Life Sciences is headquartered in Franklin, United States.
B2S Life Sciences operates in the following industries: Biotechnology.
B2S Life Sciences has approximately 45 employees.
Top alternatives and competitors to B2S Life Sciences include 23andMe, Evadata, Anlitiks Inc., IRLCA, Employ America. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
B2S Life Sciences and 23andMe are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors B2S Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes